CELLGEN BIOPHARMA is the pharma industry's fastest-growing business. Since 2017, the company has been manufacturing, marketing, and exporting pharmaceutical formulations and nutraceuticals in the dosage forms of Tablets, Capsules, Oral Liquids, Dry Syrup, Dry Powder & Liquid Injectables, Lyophilized Injection, Ointments, Creams, and Sachets in a variety of therapeutic segments.
With contemporary facilities, expertise and knowhow of resources that are on par with the finest in the country, the firm is set for vertical expansion. The company boost cutting-edge production facilities and adheres to all of the Food and Drug Administration's particular criteria (FDA). WHO-GMP and ISO 9001 quality standards have validated the company's commitment to high product quality assurance and environmental management.
The company has a rating of "Good Performance Capability" and "Good Financial Strength" and has a constant growth rate.
With a committed administration, a resolute work force, a state-of-the-art work environment, and strong ethical principles, the firm continues to seek avenues of growth and development, focused on the Domestic and Export Markets.